Bristol-Myers Stalled Cancer Drug Tied to Celgene Deal, Suit Says - Bloomberg Law

Retrieved on: 2021-10-07 21:11:15

Tags for this article:

Click the tags to see associated articles and topics

Bristol-Myers Stalled Cancer Drug Tied to Celgene Deal, Suit Says - Bloomberg Law. View article details on hiswai:

Excerpt

A hedge fund sued Bristol-Myers Squibb Co. and its executives for allegedly making misleading statements about a cancer therapy drug tied to the ...

Article found on: news.bloomberglaw.com